Regional 5-hydroxyindoleacetic acid production in humans

Veno-arterial plasma concentration differences and regional organ plasma flows were used to quantify the relative amounts of 5-hydroxyindoleacetic acid (5-HIAA) contributed by various sites into the peripheral circulation. Positive venoarterial concentration gradients were found in the hepatosplanchnic, forearm, cardiac and jugular vessels in the healthy subjects. The renal circulation was determined to be the principal site of 5-HIAA clearance, extracting 18 +/- 2 nmol/min. The gut was the greatest contributor to the total 5-HIAA plasma pool with the relative contributions of the various organs being as follows: hepatosplanchnic organs 58%, skeletal muscle 26%, brain 6% and the heart 3%. The source of 5-HIAA stemming from these regional beds remains unknown, it may derive from serotonin taken up by and deaminated in ubiquitous endothelial cells, enterochromaffin cells of the gut, peripheral serotonergic nerves, serotonin turnover in platelets or perhaps the metabolism of serotonin taken up by sympathetic nerves. To test the latter hypothesis we examined 23 patients with chronic congestive heart failure and 9 patients with pure autonomic failure to investigate the possible effects of sympathetic nervous system overactivity and underactivity on peripheral 5-HIAA production and plasma 5-HIAA concentration. The resting arterial plasma 5-HIAA concentration in the heart failure patients was increased three-fold. This elevated plasma 5-HIAA concentration was attributable to an increased rate of whole body 5-HIAA production. The arterial 5-HIAA plasma concentration in the autonomic failure patients was paradoxically elevated, being 70% greater than that of the healthy subjects. The increased 5-HIAA plasma concentration in these patients was accounted for by a reduction in 5-HIAA plasma clearance. In all subjects studied there was a weak relationship only between total body norepinephrine spillover to plasma and the arterial 5-HIAA plasma concentration. We found that in healthy subjects the overflow of 5-HIAA into the hepatic vein was significantly related to the underlying degree of sympathetic activity. It can be concluded that 5-HIAA is produced at a number of sites throughout the body with the arterial plasma concentration being dependent on both the level of production and plasma clearance. By far the majority of 5-HIAA in plasma is derived from the gut with only minimal contribution from the brain.     

Superconductivity and magnetic interactions in Yb1.2−x Eu x Mo6S8 pseudoternary compounds

The superconducting and magnetic properties of the Yb_1.2–x Eu _x Mo₆S₈ series of compounds have been investigated by means of ac magnetic susceptibility, electrical resistivity, and upper critical magnetic fieldH _c2 measurements. The superconducting transition temperature at ambient pressure is depressed by Eu additions, until superconductivity disappears completely atx0.7. For Eu concentrationsx<0.45,H _c2 is enhanced at low temperatures and exceeds the values for pure Yb_1.2Mo₆S₈. The temperature dependence ofH _c2 for the various Yb_1.2–x Eu _x Mo₆S₈ compounds is analyzed using a multiple pair-breaking theory that includes the compensation of the applied magnetic field by the negative exchange field produced by antiferromagnetic interactions between the conduction electron spins and the Eu²⁺ spins (Jaccarino-Peter effect). Hydrostatic pressure was found to induce superconductivity in all Eu-rich compositions that were not superconducting at ambient pressure.     

On the thermal stability of xanthan gum

The thermal stability of xanthan gum in dilute aqueous solutions at 90°C is considered. The relative viscosity as a function of ageing time is discussed, and it has been found to depend on the polymer concentration and conformation as well as on the salt content. The effectiveness of a quencher demonstrates the existence of a free-radical process in the degradation. During ageing, the molecular weight first decreases by rapid random hydrolysis of the main chain and loss of the pyruvate and acetate substituents. Later, oligomers are formed corresponding to a breakdown of both the side chain and the main chain. The identification of cellodextrins in the oligomer pool demonstrates the second effect.     

Efficient Reduction of NO x by H2 Under Oxygen-Rich Conditions over Pd/TiO2 Catalysts: An in situ DRIFTS Study

The H₂/NO/O₂ reaction under lean-burn conditions has been studied by means of in situ DRIFTS, reactor measurements and temperature-programmed desorption with the aim of understanding the very different behavior of Pd/TiO₂ and Pd/Al₂O₃ catalysts. The former deliver very high NO _x conversions (70-80%) with good N₂ selectivity whereas the latter show very low activity. In addition, PdTiO₂ exhibits two distinct NO _x reduction pathways, thus greatly extending the useful temperature range. It is shown that the PdTiO₂ low-temperature channel involves adsorption and subsequent dissociation of NO on reduced (Pd⁰) metal sites. The low activity of PdAl₂O₃ is a consequence of palladium remaining in an oxidized state under reaction conditions. The high-temperature NO reduction channel found with PdTiO₂ is associated with the generation and subsequent reaction of NH _x species.     

Architectures for Fast Transcoding of H.264/AVC to Quality-Scalable SVC Streams

The scalable extension of H.264/AVC (SVC) was recently standardized, and offers scalability at a minor penalty in rate-distortion efficiency when compared to single-layer H.264/AVC coding. In SVC, a scaled version of the original video sequence can easily be extracted by dropping layers from the stream. However, most of the video content nowadays is still produced in a single-layer format. While decoding and reencoding is a possible solution to introduce scalability in the existing bitstreams, this is an approach which requires a tremendous amount of time and effort. In this paper, we show that transcoding can be used to intelligently derive scalable bitstreams from existing single-layer streams. We focus on SNR scalability, and introduce techniques that are able to create multiple quality layers in the bitstreams. We also discuss bitstream rewriting from SVC to H.264/AVC, and examine how our newly proposed architectures can benefit from the changes that were introduced for bitstream rewriting. Architectures with different rate distribution flexibility and computational complexity are discussed. Rate-distortion performance of transcoding is shown to be comparable to that of reencoding at a fraction of the time needed for the latter.     

Prosthetic valve endocarditis: superiority of surgical valve replacement versus medical therapy only

The objective of our study was to assess the long-term outcome of patients with prosthetic valve endocarditis. We used a multicenter, prospective, observational study design. Six university teaching hospitals with high volume cardiothoracic surgery participated. Seventy-four patients with prosthetic valve endocarditis as defined by explicit, objective criteria were selected for participation. All patients were followed up prospectively for 1 year. Thirty-one percent and 69% had development of endocarditis within 60 days of valve insertion ("early") and after 60 days ("late"), respectively. The most common causes were Staphylococcus epidermidis (40%), Staphylococcus aureus (20%), streptococcal species (18%), and aerobic gram-negative bacilli (11%). Physical signs of endocarditis (new or changing murmur, stigmata, emboli) were seen in 58%. At 6 months and 12 months, mortality was 46% and 47%, respectively. Surgical replacement of the infected valve led to significantly lower mortality (23%) as compared with medical therapy alone (56%), as assessed by both univariate and multivariate analyses (p < 0.05). Improved outcome was seen for the surgical group even when controlling for severity of illness at time of diagnosis. From these findings we conclude that accurate assessment of outcome in prosthetic valve endocarditis requires long-term follow-up of at least 6 months following diagnosis. Surgical therapy warrants greater scrutiny; evaluation in controlled clinical trials is appropriate.